Efficacy and acceptability of 15(S)-15-methyl-prostaglandin E2-methyl ester for midtrimester pregnancy termination.
D000019:Abortifacient Agents / Q000008:administration & dosage* / Q000009:adverse effects; D000028:Abortion, Induced; D000293:Adolescent; D000328:Adult; D002584:Cervix Uteri / Q000187:drug effects; D004106:Dilatation; D004952:Esters / Q000008:administration & dosage; D000431:Ethanol / Q000008:administration & dosage; D005260:Female; D005318:Fetal Heart; D006339:Heart Rate; D006801:Humans; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D009119:Muscle Contraction; D011247:Pregnancy; D011262:Pregnancy Trimester, Second; D011453:Prostaglandins / Q000008:administration & dosage* / Q000009:adverse effects; D012624:Seaweed; D012768:Shivering; D014599:Uterus / Q000502:physiology; D014839:Vomiting / Q000139:chemically induced
D000019:Abortifacient Agents; D004952:Esters; D011453:Prostaglandins; D000431:Ethanol